Dietary and Physical Activity Interventions in Gynecologic Oncology: Mechanisms, Guidelines, and Clinical Evidence. [PDF]
Shah SS, Jackovic A, Alhilli M.
europepmc +1 more source
Abstract Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in ...
Martin Duval +8 more
wiley +1 more source
Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? [PDF]
Cripe, James C +8 more
core +1 more source
What's New? The establishment in 2014 of the population‐based cancer registry (PBCR) of Bhutan created new opportunities for understanding national cancer trends, which previously were anticipated from data in neighbouring countries. This study presents the first nine‐year summary of cancer patterns in Bhutan, derived from PBCR data. From 2014 to 2022,
Phub Tshering +9 more
wiley +1 more source
Role of Minimally Invasive Surgery in Gynecologic Oncology
Lesley B. Conrad +6 more
openalex +2 more sources
What's New? Increasing cancer incidence and mortality in low‐ and middle‐income countries has heightened concerns about limited resources and barriers to care. This challenge is particularly urgent in Sub‐Saharan Africa (SSA), where cancer rates are rising sharply. Here, data from population‐based cancer registries in nine SSA countries was assessed to
Tamara König +19 more
wiley +1 more source
Pubertal timing and incident uterine cancer in the Sister Study cohort
What's New? Younger age at menarche is an established risk factor for uterine cancer. Age at onset of breast development (thelarche), the earliest marker of pubertal estrogen exposure unopposed by progesterone, may also be relevant to uterine cancer risk, but this association has not been explored. Using data from the US prospective Sister Study cohort,
Ariayana N. Harrell +4 more
wiley +1 more source
Evaluation of a Quality-Improvement Initiative to Address Nutritional Anemia in Gynecologic Oncology. [PDF]
Foley OW +8 more
europepmc +1 more source
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial) [PDF]
Kensuke Sakai +7 more
openalex +1 more source

